+1 347 708 0418
The Blood Substitute market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Blood Substitute size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Blood Substitute market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Blood Substitute market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
HBOC
PFBOC
Market segment by Application, can be divided into
Hospital
Clinic
Research Institute
Others
Market segment by players, this report covers
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Blood Substitute
1.2 Classification of Blood Substitute by Type
1.2.1 Overview: Global Blood Substitute Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Blood Substitute Revenue Market Share by Type in 2020
1.2.3 HBOC
1.2.4 PFBOC
1.3 Global Blood Substitute Market by Application
1.3.1 Overview: Global Blood Substitute Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Others
1.4 Global Blood Substitute Market Size & Forecast
1.5 Global Blood Substitute Market Size and Forecast by Region
1.5.1 Global Blood Substitute Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Blood Substitute Market Size by Region, (2016-2021)
1.5.3 North America Blood Substitute Market Size and Prospect (2016-2026)
1.5.4 Europe Blood Substitute Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Blood Substitute Market Size and Prospect (2016-2026)
1.5.6 South America Blood Substitute Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Blood Substitute Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Blood Substitute Market Drivers
1.6.2 Blood Substitute Market Restraints
1.6.3 Blood Substitute Trends Analysis
2 Company Profiles
2.1 Dextro-Sang Corporation
2.1.1 Dextro-Sang Corporation Details
2.1.2 Dextro-Sang Corporation Major Business
2.1.3 Dextro-Sang Corporation Blood Substitute Product and Solutions
2.1.4 Dextro-Sang Corporation Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Dextro-Sang Corporation Recent Developments and Future Plans
2.2 BioPure Corporation
2.2.1 BioPure Corporation Details
2.2.2 BioPure Corporation Major Business
2.2.3 BioPure Corporation Blood Substitute Product and Solutions
2.2.4 BioPure Corporation Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioPure Corporation Recent Developments and Future Plans
2.3 Sangart
2.3.1 Sangart Details
2.3.2 Sangart Major Business
2.3.3 Sangart Blood Substitute Product and Solutions
2.3.4 Sangart Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sangart Recent Developments and Future Plans
2.4 Northfield Laboratories
2.4.1 Northfield Laboratories Details
2.4.2 Northfield Laboratories Major Business
2.4.3 Northfield Laboratories Blood Substitute Product and Solutions
2.4.4 Northfield Laboratories Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Northfield Laboratories Recent Developments and Future Plans
2.5 Baxter International
2.5.1 Baxter International Details
2.5.2 Baxter International Major Business
2.5.3 Baxter International Blood Substitute Product and Solutions
2.5.4 Baxter International Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Baxter International Recent Developments and Future Plans
2.6 Dentritech
2.6.1 Dentritech Details
2.6.2 Dentritech Major Business
2.6.3 Dentritech Blood Substitute Product and Solutions
2.6.4 Dentritech Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Dentritech Recent Developments and Future Plans
2.7 FluorO2 Therapeutics
2.7.1 FluorO2 Therapeutics Details
2.7.2 FluorO2 Therapeutics Major Business
2.7.3 FluorO2 Therapeutics Blood Substitute Product and Solutions
2.7.4 FluorO2 Therapeutics Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 FluorO2 Therapeutics Recent Developments and Future Plans
2.8 Nuvox Pharma
2.8.1 Nuvox Pharma Details
2.8.2 Nuvox Pharma Major Business
2.8.3 Nuvox Pharma Blood Substitute Product and Solutions
2.8.4 Nuvox Pharma Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Nuvox Pharma Recent Developments and Future Plans
2.9 Alpha Therapeutic Corporation
2.9.1 Alpha Therapeutic Corporation Details
2.9.2 Alpha Therapeutic Corporation Major Business
2.9.3 Alpha Therapeutic Corporation Blood Substitute Product and Solutions
2.9.4 Alpha Therapeutic Corporation Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Alpha Therapeutic Corporation Recent Developments and Future Plans
2.10 HemoBioTech
2.10.1 HemoBioTech Details
2.10.2 HemoBioTech Major Business
2.10.3 HemoBioTech Blood Substitute Product and Solutions
2.10.4 HemoBioTech Blood Substitute Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 HemoBioTech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Blood Substitute Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Blood Substitute Players Market Share
3.2.2 Top 10 Blood Substitute Players Market Share
3.2.3 Market Competition Trend
3.3 Blood Substitute Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Blood Substitute Revenue and Market Share by Type (2016-2021)
4.2 Global Blood Substitute Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Blood Substitute Revenue Market Share by Application (2016-2021)
5.2 Blood Substitute Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Blood Substitute Revenue by Type (2016-2026)
6.2 North America Blood Substitute Revenue by Application (2016-2026)
6.3 North America Blood Substitute Market Size by Country
6.3.1 North America Blood Substitute Revenue by Country (2016-2026)
6.3.2 United States Blood Substitute Market Size and Forecast (2016-2026)
6.3.3 Canada Blood Substitute Market Size and Forecast (2016-2026)
6.3.4 Mexico Blood Substitute Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Blood Substitute Revenue by Type (2016-2026)
7.2 Europe Blood Substitute Revenue by Application (2016-2026)
7.3 Europe Blood Substitute Market Size by Country
7.3.1 Europe Blood Substitute Revenue by Country (2016-2026)
7.3.2 Germany Blood Substitute Market Size and Forecast (2016-2026)
7.3.3 France Blood Substitute Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Blood Substitute Market Size and Forecast (2016-2026)
7.3.5 Russia Blood Substitute Market Size and Forecast (2016-2026)
7.3.6 Italy Blood Substitute Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Blood Substitute Revenue by Type (2016-2026)
8.2 Asia-Pacific Blood Substitute Revenue by Application (2016-2026)
8.3 Asia-Pacific Blood Substitute Market Size by Region
8.3.1 Asia-Pacific Blood Substitute Revenue by Region (2016-2026)
8.3.2 China Blood Substitute Market Size and Forecast (2016-2026)
8.3.3 Japan Blood Substitute Market Size and Forecast (2016-2026)
8.3.4 South Korea Blood Substitute Market Size and Forecast (2016-2026)
8.3.5 India Blood Substitute Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Blood Substitute Market Size and Forecast (2016-2026)
8.3.7 Australia Blood Substitute Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Blood Substitute Revenue by Type (2016-2026)
9.2 South America Blood Substitute Revenue by Application (2016-2026)
9.3 South America Blood Substitute Market Size by Country
9.3.1 South America Blood Substitute Revenue by Country (2016-2026)
9.3.2 Brazil Blood Substitute Market Size and Forecast (2016-2026)
9.3.3 Argentina Blood Substitute Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Blood Substitute Revenue by Type (2016-2026)
10.2 Middle East & Africa Blood Substitute Revenue by Application (2016-2026)
10.3 Middle East & Africa Blood Substitute Market Size by Country
10.3.1 Middle East & Africa Blood Substitute Revenue by Country (2016-2026)
10.3.2 Turkey Blood Substitute Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Blood Substitute Market Size and Forecast (2016-2026)
10.3.4 UAE Blood Substitute Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Blood Substitute Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Blood Substitute Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Blood Substitute Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Blood Substitute Revenue (USD Million) by Region (2016-2021)
Table 5. Global Blood Substitute Revenue Market Share by Region (2021-2026)
Table 6. Dextro-Sang Corporation Corporate Information, Head Office, and Major Competitors
Table 7. Dextro-Sang Corporation Major Business
Table 8. Dextro-Sang Corporation Blood Substitute Product and Solutions
Table 9. Dextro-Sang Corporation Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioPure Corporation Corporate Information, Head Office, and Major Competitors
Table 11. BioPure Corporation Major Business
Table 12. BioPure Corporation Blood Substitute Product and Solutions
Table 13. BioPure Corporation Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sangart Corporate Information, Head Office, and Major Competitors
Table 15. Sangart Major Business
Table 16. Sangart Blood Substitute Product and Solutions
Table 17. Sangart Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Northfield Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Northfield Laboratories Major Business
Table 20. Northfield Laboratories Blood Substitute Product and Solutions
Table 21. Northfield Laboratories Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Baxter International Corporate Information, Head Office, and Major Competitors
Table 23. Baxter International Major Business
Table 24. Baxter International Blood Substitute Product and Solutions
Table 25. Baxter International Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Dentritech Corporate Information, Head Office, and Major Competitors
Table 27. Dentritech Major Business
Table 28. Dentritech Blood Substitute Product and Solutions
Table 29. Dentritech Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. FluorO2 Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. FluorO2 Therapeutics Major Business
Table 32. FluorO2 Therapeutics Blood Substitute Product and Solutions
Table 33. FluorO2 Therapeutics Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Nuvox Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Nuvox Pharma Major Business
Table 36. Nuvox Pharma Blood Substitute Product and Solutions
Table 37. Nuvox Pharma Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Alpha Therapeutic Corporation Corporate Information, Head Office, and Major Competitors
Table 39. Alpha Therapeutic Corporation Major Business
Table 40. Alpha Therapeutic Corporation Blood Substitute Product and Solutions
Table 41. Alpha Therapeutic Corporation Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. HemoBioTech Corporate Information, Head Office, and Major Competitors
Table 43. HemoBioTech Major Business
Table 44. HemoBioTech Blood Substitute Product and Solutions
Table 45. HemoBioTech Blood Substitute Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Blood Substitute Revenue (USD Million) by Players (2019-2021)
Table 47. Global Blood Substitute Revenue Share by Players (2019-2021)
Table 48. Breakdown of Blood Substitute by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Blood Substitute Players Head Office, Products and Services Provided
Table 50. Blood Substitute Mergers & Acquisitions in the Past Five Years
Table 51. Blood Substitute New Entrants and Expansion Plans
Table 52. Global Blood Substitute Revenue (USD Million) by Type (2016-2021)
Table 53. Global Blood Substitute Revenue Share by Type (2016-2021)
Table 54. Global Blood Substitute Revenue Forecast by Type (2021-2026)
Table 55. Global Blood Substitute Revenue by Application (2016-2021)
Table 56. Global Blood Substitute Revenue Forecast by Application (2021-2026)
Table 57. North America Blood Substitute Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Blood Substitute Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Blood Substitute Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Blood Substitute Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Blood Substitute Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Blood Substitute Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Blood Substitute Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Blood Substitute Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Blood Substitute Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Blood Substitute Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Blood Substitute Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Blood Substitute Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Blood Substitute Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Blood Substitute Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Blood Substitute Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Blood Substitute Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Blood Substitute Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Blood Substitute Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Blood Substitute Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Blood Substitute Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Blood Substitute Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Blood Substitute Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Blood Substitute Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Blood Substitute Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Blood Substitute Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Blood Substitute Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Blood Substitute Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Blood Substitute Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Blood Substitute Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Blood Substitute Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Blood Substitute Picture
Figure 2. Global Blood Substitute Revenue Market Share by Type in 2020
Figure 3. HBOC
Figure 4. PFBOC
Figure 5. Blood Substitute Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Research Institute Picture
Figure 9. Others Picture
Figure 10. Global Blood Substitute Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Blood Substitute Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Blood Substitute Revenue Market Share by Region (2016-2026)
Figure 13. Global Blood Substitute Revenue Market Share by Region in 2020
Figure 14. North America Blood Substitute Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Blood Substitute Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Blood Substitute Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Blood Substitute Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Blood Substitute Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Blood Substitute Market Drivers
Figure 20. Blood Substitute Market Restraints
Figure 21. Blood Substitute Market Trends
Figure 22. Dextro-Sang Corporation Recent Developments and Future Plans
Figure 23. BioPure Corporation Recent Developments and Future Plans
Figure 24. Sangart Recent Developments and Future Plans
Figure 25. Northfield Laboratories Recent Developments and Future Plans
Figure 26. Baxter International Recent Developments and Future Plans
Figure 27. Dentritech Recent Developments and Future Plans
Figure 28. FluorO2 Therapeutics Recent Developments and Future Plans
Figure 29. Nuvox Pharma Recent Developments and Future Plans
Figure 30. Alpha Therapeutic Corporation Recent Developments and Future Plans
Figure 31. HemoBioTech Recent Developments and Future Plans
Figure 32. Global Blood Substitute Revenue Share by Players in 2020
Figure 33. Blood Substitute Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Blood Substitute Revenue Market Share in 2020
Figure 35. Global Top 10 Players Blood Substitute Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Blood Substitute Revenue Share by Type in 2020
Figure 38. Global Blood Substitute Market Share Forecast by Type (2021-2026)
Figure 39. Global Blood Substitute Revenue Share by Application in 2020
Figure 40. Global Blood Substitute Market Share Forecast by Application (2021-2026)
Figure 41. North America Blood Substitute Sales Market Share by Type (2016-2026)
Figure 42. North America Blood Substitute Sales Market Share by Application (2016-2026)
Figure 43. North America Blood Substitute Revenue Market Share by Country (2016-2026)
Figure 44. United States Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Blood Substitute Sales Market Share by Type (2016-2026)
Figure 48. Europe Blood Substitute Sales Market Share by Application (2016-2026)
Figure 49. Europe Blood Substitute Revenue Market Share by Country (2016-2026)
Figure 50. Germany Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Blood Substitute Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Blood Substitute Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Blood Substitute Revenue Market Share by Region (2016-2026)
Figure 58. China Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Blood Substitute Sales Market Share by Type (2016-2026)
Figure 65. South America Blood Substitute Sales Market Share by Application (2016-2026)
Figure 66. South America Blood Substitute Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Blood Substitute Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Blood Substitute Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Blood Substitute Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Blood Substitute Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Buy
